The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Osteoporosis Therapeutics Market Research Report 2025
Synopsis
Osteoporosis is a silent epidemic and as per the WHO declarations, it is a priority health issue. Osteoporosis is a disruption of bone architecture and decrease in bone mass, leading to a number of complications including increased chances of bone fractures and reduced bone strength. The most common sites of osteoporosis are the spine, hip and forearm, although it also affects other body parts.
The global Osteoporosis Therapeutics market was valued at US$ 10420 million in 2023 and is anticipated to reach US$ 12110 million by 2030, witnessing a CAGR of 2.2% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Osteoporosis Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Osteoporosis Therapeutics.
Report Scope
The Osteoporosis Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Osteoporosis Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Distribution Channel, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Osteoporosis Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Distribution Channel, and by regions.
Market Segmentation
By Company
Warner Chilcott
Merck & Co.
Roche
Novartis
Ono
Astellas Pharma
Procter & Gamble
Sumitomo Pharmaceuticals
Servier
Eli Lilly
Pfizer
Amgen
Chugai
Segment by Type
Bisphosphonates
Hormones
Strontium Ranelate
Raloxifene
Denosumab
Others
Segment by Distribution Channel
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Distribution Channel, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Osteoporosis Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Distribution Channel, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Osteoporosis is a silent epidemic and as per the WHO declarations, it is a priority health issue. Osteoporosis is a disruption of bone architecture and decrease in bone mass, leading to a number of complications including increased chances of bone fractures and reduced bone strength. The most common sites of osteoporosis are the spine, hip and forearm, although it also affects other body parts.
The global Osteoporosis Therapeutics market was valued at US$ 10420 million in 2023 and is anticipated to reach US$ 12110 million by 2030, witnessing a CAGR of 2.2% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Osteoporosis Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Osteoporosis Therapeutics.
Report Scope
The Osteoporosis Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Osteoporosis Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Distribution Channel, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Osteoporosis Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Distribution Channel, and by regions.
Market Segmentation
By Company
Warner Chilcott
Merck & Co.
Roche
Novartis
Ono
Astellas Pharma
Procter & Gamble
Sumitomo Pharmaceuticals
Servier
Eli Lilly
Pfizer
Amgen
Chugai
Segment by Type
Bisphosphonates
Hormones
Strontium Ranelate
Raloxifene
Denosumab
Others
Segment by Distribution Channel
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Distribution Channel, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Osteoporosis Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Distribution Channel, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Osteoporosis Therapeutics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Bisphosphonates
1.2.3 Hormones
1.2.4 Strontium Ranelate
1.2.5 Raloxifene
1.2.6 Denosumab
1.2.7 Others
1.3 Market by Distribution Channel
1.3.1 Global Osteoporosis Therapeutics Market Growth by Distribution Channel: 2019 VS 2023 VS 2030
1.3.2 Hospital Pharmacies
1.3.3 Online Pharmacies
1.3.4 Retail Pharmacies
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Osteoporosis Therapeutics Market Perspective (2019-2030)
2.2 Osteoporosis Therapeutics Growth Trends by Region
2.2.1 Global Osteoporosis Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Osteoporosis Therapeutics Historic Market Size by Region (2019-2024)
2.2.3 Osteoporosis Therapeutics Forecasted Market Size by Region (2025-2030)
2.3 Osteoporosis Therapeutics Market Dynamics
2.3.1 Osteoporosis Therapeutics Industry Trends
2.3.2 Osteoporosis Therapeutics Market Drivers
2.3.3 Osteoporosis Therapeutics Market Challenges
2.3.4 Osteoporosis Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Osteoporosis Therapeutics Players by Revenue
3.1.1 Global Top Osteoporosis Therapeutics Players by Revenue (2019-2024)
3.1.2 Global Osteoporosis Therapeutics Revenue Market Share by Players (2019-2024)
3.2 Global Osteoporosis Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Osteoporosis Therapeutics Revenue
3.4 Global Osteoporosis Therapeutics Market Concentration Ratio
3.4.1 Global Osteoporosis Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Osteoporosis Therapeutics Revenue in 2023
3.5 Osteoporosis Therapeutics Key Players Head office and Area Served
3.6 Key Players Osteoporosis Therapeutics Product Solution and Service
3.7 Date of Enter into Osteoporosis Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Osteoporosis Therapeutics Breakdown Data by Type
4.1 Global Osteoporosis Therapeutics Historic Market Size by Type (2019-2024)
4.2 Global Osteoporosis Therapeutics Forecasted Market Size by Type (2025-2030)
5 Osteoporosis Therapeutics Breakdown Data by Distribution Channel
5.1 Global Osteoporosis Therapeutics Historic Market Size by Distribution Channel (2019-2024)
5.2 Global Osteoporosis Therapeutics Forecasted Market Size by Distribution Channel (2025-2030)
6 North America
6.1 North America Osteoporosis Therapeutics Market Size (2019-2030)
6.2 North America Osteoporosis Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Osteoporosis Therapeutics Market Size by Country (2019-2024)
6.4 North America Osteoporosis Therapeutics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Osteoporosis Therapeutics Market Size (2019-2030)
7.2 Europe Osteoporosis Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Osteoporosis Therapeutics Market Size by Country (2019-2024)
7.4 Europe Osteoporosis Therapeutics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Osteoporosis Therapeutics Market Size (2019-2030)
8.2 Asia-Pacific Osteoporosis Therapeutics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Osteoporosis Therapeutics Market Size by Region (2019-2024)
8.4 Asia-Pacific Osteoporosis Therapeutics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Osteoporosis Therapeutics Market Size (2019-2030)
9.2 Latin America Osteoporosis Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Osteoporosis Therapeutics Market Size by Country (2019-2024)
9.4 Latin America Osteoporosis Therapeutics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Osteoporosis Therapeutics Market Size (2019-2030)
10.2 Middle East & Africa Osteoporosis Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Osteoporosis Therapeutics Market Size by Country (2019-2024)
10.4 Middle East & Africa Osteoporosis Therapeutics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Warner Chilcott
11.1.1 Warner Chilcott Company Detail
11.1.2 Warner Chilcott Business Overview
11.1.3 Warner Chilcott Osteoporosis Therapeutics Introduction
11.1.4 Warner Chilcott Revenue in Osteoporosis Therapeutics Business (2019-2024)
11.1.5 Warner Chilcott Recent Development
11.2 Merck & Co.
11.2.1 Merck & Co. Company Detail
11.2.2 Merck & Co. Business Overview
11.2.3 Merck & Co. Osteoporosis Therapeutics Introduction
11.2.4 Merck & Co. Revenue in Osteoporosis Therapeutics Business (2019-2024)
11.2.5 Merck & Co. Recent Development
11.3 Roche
11.3.1 Roche Company Detail
11.3.2 Roche Business Overview
11.3.3 Roche Osteoporosis Therapeutics Introduction
11.3.4 Roche Revenue in Osteoporosis Therapeutics Business (2019-2024)
11.3.5 Roche Recent Development
11.4 Novartis
11.4.1 Novartis Company Detail
11.4.2 Novartis Business Overview
11.4.3 Novartis Osteoporosis Therapeutics Introduction
11.4.4 Novartis Revenue in Osteoporosis Therapeutics Business (2019-2024)
11.4.5 Novartis Recent Development
11.5 Ono
11.5.1 Ono Company Detail
11.5.2 Ono Business Overview
11.5.3 Ono Osteoporosis Therapeutics Introduction
11.5.4 Ono Revenue in Osteoporosis Therapeutics Business (2019-2024)
11.5.5 Ono Recent Development
11.6 Astellas Pharma
11.6.1 Astellas Pharma Company Detail
11.6.2 Astellas Pharma Business Overview
11.6.3 Astellas Pharma Osteoporosis Therapeutics Introduction
11.6.4 Astellas Pharma Revenue in Osteoporosis Therapeutics Business (2019-2024)
11.6.5 Astellas Pharma Recent Development
11.7 Procter & Gamble
11.7.1 Procter & Gamble Company Detail
11.7.2 Procter & Gamble Business Overview
11.7.3 Procter & Gamble Osteoporosis Therapeutics Introduction
11.7.4 Procter & Gamble Revenue in Osteoporosis Therapeutics Business (2019-2024)
11.7.5 Procter & Gamble Recent Development
11.8 Sumitomo Pharmaceuticals
11.8.1 Sumitomo Pharmaceuticals Company Detail
11.8.2 Sumitomo Pharmaceuticals Business Overview
11.8.3 Sumitomo Pharmaceuticals Osteoporosis Therapeutics Introduction
11.8.4 Sumitomo Pharmaceuticals Revenue in Osteoporosis Therapeutics Business (2019-2024)
11.8.5 Sumitomo Pharmaceuticals Recent Development
11.9 Servier
11.9.1 Servier Company Detail
11.9.2 Servier Business Overview
11.9.3 Servier Osteoporosis Therapeutics Introduction
11.9.4 Servier Revenue in Osteoporosis Therapeutics Business (2019-2024)
11.9.5 Servier Recent Development
11.10 Eli Lilly
11.10.1 Eli Lilly Company Detail
11.10.2 Eli Lilly Business Overview
11.10.3 Eli Lilly Osteoporosis Therapeutics Introduction
11.10.4 Eli Lilly Revenue in Osteoporosis Therapeutics Business (2019-2024)
11.10.5 Eli Lilly Recent Development
11.11 Pfizer
11.11.1 Pfizer Company Detail
11.11.2 Pfizer Business Overview
11.11.3 Pfizer Osteoporosis Therapeutics Introduction
11.11.4 Pfizer Revenue in Osteoporosis Therapeutics Business (2019-2024)
11.11.5 Pfizer Recent Development
11.12 Amgen
11.12.1 Amgen Company Detail
11.12.2 Amgen Business Overview
11.12.3 Amgen Osteoporosis Therapeutics Introduction
11.12.4 Amgen Revenue in Osteoporosis Therapeutics Business (2019-2024)
11.12.5 Amgen Recent Development
11.13 Chugai
11.13.1 Chugai Company Detail
11.13.2 Chugai Business Overview
11.13.3 Chugai Osteoporosis Therapeutics Introduction
11.13.4 Chugai Revenue in Osteoporosis Therapeutics Business (2019-2024)
11.13.5 Chugai Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
